RTD Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$553K Buy
461
+41
+10% +$41.9K 0.06% 90
2026
Q1
$386K Sell
420
-67
-14% -$67.9K 0.05% 95
2025
Q4
$523K Buy
+487
New +$466K 0.06% 84
2025
Q3
Sell
-260
Closed -$203K 108
2025
Q2
$203K Sell
260
-20
-7% -$15.5K 0.03% 107
2025
Q1
$231K Buy
+280
New +$233K 0.03% 111

Other funds holding LLY

RTD Financial Advisors's LLY Position: Q2 2026 in Review

RTD Financial Advisors increased its Eli Lilly (LLY) stake by 9.8% in Q2 2026, buying an estimated $41.9K and bringing the position to 461 shares worth $553K. The position accounts for 0.06% of the portfolio, ranked #90.

RTD Financial Advisors first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. 1,583 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • RTD Financial Advisors held 461 shares of Eli Lilly worth $553K as of Q2 2026.
  • RTD Financial Advisors bought 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 0.06% of RTD Financial Advisors's portfolio in Q2 2026, its #90 holding.
  • RTD Financial Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • 1,583 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on RTD Financial Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.